
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia
2021; Springer Science+Business Media; Volume: 39; Issue: 3 Linguagem: Inglês
10.1007/s10637-020-01028-8
ISSN1573-0646
AutoresRenata Scopim‐Ribeiro, João Agostinho Machado‐Neto, Christopher A. Eide, Juan Luiz Coelho‐Silva, Bruna Alves Fenerich, Jaqueline Cristina Fernandes, Priscila Santos Scheucher, Samantha L. Savage, Paula de Melo Campos, Sara Teresinha Olalla Saad, Leonardo de Carvalho Palma, Lorena Lôbo Figueiredo-Pontes, Belinda Pinto Simões, Eduardo Magalhães Rego, Cristina E. Tognon, Brian J. Druker, Fabı́ola Traina,
Tópico(s)Acute Myeloid Leukemia Research
Referência(s)